Condition
Post-Stroke Spasticity
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
60%
3 of 5 completed with results
Key Signals
3 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 3 (3)
Trial Status
Completed5
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07523243Not ApplicableNot Yet Recruiting
Effect of Extracorporeal Shock Wave Therapy on Spasticity and Mobility in Stroke Patients
NCT06381999CompletedPrimary
Validity and Inter-rater Reliability for Early Recognition of Spasticity Using the Decision Tree Tool
NCT01251367Phase 3CompletedPrimary
Dysport® Adult Lower Limb Spasticity Follow-on Study
NCT03251521CompletedPrimary
Pain During Injection With Botulinum Toxin in Post-stroke Spasticity Treatment
NCT00460564Phase 3CompletedPrimary
Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity
NCT00460655Phase 3CompletedPrimary
Study of GSK1358820 In Patients With Post-Stroke Lower Limb Spasticity
Showing all 6 trials